CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study

Ishani Wickramage1 Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB), University of Colombo, Colombo, Sri LankaCorrespondence[email protected]

Kamani Hemamala Tennekoon1 Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB), University of Colombo, Colombo, Sri Lanka

Merenchi Arachchige Yasantha Ariyaratne2 National Cancer Institute, Maharagama, Sri Lanka

Asanka Sudeshini Hewage1 Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB), University of Colombo, Colombo, Sri Lanka

Tharmini Sundralingam1 Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB), University of Colombo, Colombo, Sri Lanka

Pages 111-120 | Published online: 06 Mar 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

National Cancer Control ProgramCancer Incidence Data Sri Lanka 2010 12th pubColomboNational Cancer Control Program, Ministry of Health, Nutrition and Indigenous Medicine2016
Google Scholar
Zafra-CeresMde HaroTFarez-VidalEInfluence of CYP2D6 polymorphisms on serum levels of tamoxifen metabolites in Spanish women with breast cancerInt J Med Sci201310793293723781139
PubMed Web of Science ®Google Scholar
HoskinsJMCareyLAMcLeodHLCYP2D6 and tamoxifen: DNA matters in breast cancerNat Rev Cancer20099857658619629072
PubMed Web of Science ®Google Scholar
RangHPDaleMMRitterJMAnticancer drugsRang and Dale’s Pharmacology7thSpainElsevier Inc2012673688
Google Scholar
BruntonLLParkerKLGoodman and Gilman’s Manual of Pharmacology and Therapeutics7thNew York, NYMcGraw-Hill2008
Google Scholar
ClarkeRLeonessaFWelchJNSkaarTCCellular and molecular pharmacology of antiestrogen action and resistancePharmacol Rev2001531257111171938
PubMed Web of Science ®Google Scholar
DeanLTamoxifen therapy and CYP2D6 Genotype. medical genetics summaries [Internet] [Created October 7, 2014. Last Update: May 3, 2016]. Avialbale from: http://www.ncbi.nlm.nih.gov/books/NBK247013Accessed September 6, 2016
Google Scholar
KlingmanLYounusJManagement of hot flashes in women with breast cancerCurr Oncol2010171818620179808
PubMed Web of Science ®Google Scholar
FisherBCostantinoJPWickerhamDLTamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJ Natl Cancer Inst19989018137113889747868
PubMed Web of Science ®Google Scholar
FisherWIJohnsonAKElkinsGRRisk factors, pathophysiology, and treatment of hot flashes in cancerCA Cancer J Clin201363316719223355109
PubMed Web of Science ®Google Scholar
Joint Formulary CommitteeBritish National FormularyLondonBMJ Group and Pharmaceutical Press2015167192
Google Scholar
PatelVSanyalAJDrug-induced steatohepatitisClin Liver Dis201317453354624099016
PubMed Web of Science ®Google Scholar
ColeLKJacobsRLVanceDETamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesisHepatology20105241258126520658461
PubMed Web of Science ®Google Scholar
RabinowichLShiboletODrug induced steatohepatitis: an uncommon culprit of a common diseaseBiomed Res Int2015201516890526273591
PubMed Web of Science ®Google Scholar
ZhaoFXiePJiangJZhangLAnWZhanYThe effect and mechanism of tamoxifen-induced hepatocyte steatosis in vitroInt J Mol Sci20141534019403024603540
PubMed Web of Science ®Google Scholar
GudbrandsenOARostTHBergeRKCauses and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liverJ Lipid Res200647102223223216864897
PubMed Web of Science ®Google Scholar
FarrellGCDrugs and steatohepatitisSemin Liver Dis200222218519412016549
PubMed Web of Science ®Google Scholar
LaroscheILetteronPFromentyBTamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and tiggers steatosis in mouse liverJ Pharmacol Exp Ther2007321252653517277197
PubMed Web of Science ®Google Scholar
PanHJChangHTLeeCHAssociation between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patientsJ Formos Med Assoc2016115641141726071793
PubMed Web of Science ®Google Scholar
U.S. National Library of Medicine [Internet]Drug record: tamoxifenLiverTox, clinical and research information on drug-induced liver injury [updated 2016 June 28]. Available from: http://livertox.nih.gov/Tamoxifen.htmAccessed September 6, 2016
Google Scholar
BriestSStearnsVTamoxifen metabolism and its effect on endocrine treatment of breast cancerClin Adv Hematol Oncol20097318519219398943
PubMedGoogle Scholar
Human Cytochrome P450 (CYP) Allele Nomenclature CommitteeCYP2D6 allele nomenclature Available from: http://www.cypalleles.ki.se/cyp2d6.htmAccessed September 6, 2016
Google Scholar
De SouzaJAOlopadeOICYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicineSemin Oncol201138226327321421116
PubMed Web of Science ®Google Scholar
ToscanoCKleinKBlievernichtImpaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing eventsPharmacogenet Genomics2006161075576517001295
PubMed Web of Science ®Google Scholar
WeerasuriyaKJayakodyRLSmithCAWolfCRTuckerGTLennardMSDebrisoquine and mephenytoin oxidation in Sinhalese: a population studyBr J Clin Pharmacol19943854664707893590
PubMed Web of Science ®Google Scholar
TharangaTDPJinadasaCMVRisamaMFGalappatthyPJayakodyRLDissanayakeVHWGenetic variants in the cytochrome P450 2D6 gene in the Sri Lankan populationIndian J Hum Genet201319439239624497701
PubMedGoogle Scholar
OhnishiTOgawaYSaibaraTCYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patientsOncol Rep200513348548915706422
PubMed Web of Science ®Google Scholar
RibeiroMPSantosAECustodioJBMitochondria: the gateway for tamoxifen-induced liver injuryToxicology2014323101824881593
PubMed Web of Science ®Google Scholar
SchweikartKMEldridgeSRSafgrenSLComparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley ratsToxicol Pathol20144281188119624670817
PubMed Web of Science ®Google Scholar
JordanVCTamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancerBr J Pharmacol2006147Suppl 1S269S27616402113
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date